Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry-Reference-Cited by-同舟云学术

Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry

Published:2014-06-27 Issue:8 Volume:23 Page:779-786
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Sinclair Susan¹²,Cunnington Marianne³,Messenheimer John⁴,Weil John³,Cragan Janet⁵,Lowensohn Richard⁶,Yerby Mark⁷,Tennis Patricia⁸

Affiliation:

1. University of North Carolina Wilmington; Wilmington NC USA

2. INC Research LLC; Wilmington NC USA

3. Worldwide Epidemiology; GlaxoSmithKline; Uxbridge UK

4. Clinical Development; GlaxoSmithKline; Research Triangle Park NC USA

5. National Center on Birth Defects and Developmental Disabilities; Centers for Disease Control and Prevention; Atlanta GA USA

6. Oregon Health and Science University; Portland OR USA

7. North Pacific Neurological Research; Portland OR USA

8. RTI International; Research Triangle Park NC USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3659/fullpdf

Reference44 articles.

1. United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Centers for Biologic Evaluation and Research Guidance for industry http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071639.pdf

2. European Medicines Agency Guideline on the exposure to medicinal products during pregnancy; need for post-authorisation data http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011303.pdf

3. How common are the “common” neurologic disorders?;Hirtz;Neurology,2007

4. Development and growth in children of epileptic mothers: a prospective controlled study;Gaily;Acta Obstet Gynecol Scand,1991

5. The teratogenicity of anticonvulsant drugs;Holmes;N Engl J Med,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER): Protocol and Methodological Considerations;Drug Safety;2023-01-22

2. Automatically Identifying Childhood Health Outcomes on Twitter for Digital Epidemiology in Pregnancy;2022-11-02

3. Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry;Birth Defects Research;2022-09-30

4. Identifying Barriers to Enrollment in Patient Pregnancy Registries: Building Evidence Through Crowdsourcing;JMIR Formative Research;2022-05-25

5. A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project;Drug Safety;2022-03-31